{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:28:33Z","timestamp":1772526513081,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.cbi.2018.04.012","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T02:31:54Z","timestamp":1523586714000},"page":"32-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562\/ADM cells by suppressing MDR1 gene\/P-glycoprotein expression"],"prefix":"10.1016","volume":"288","author":[{"given":"Jia","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2018.04.012_bib1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/14737159.2016.1227243","article-title":"Molecular monitoring of chronic myeloid leukemia: present and future","volume":"16","author":"Yeung","year":"2016","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.cbi.2018.04.012_bib2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3324\/haematol.2015.139337","article-title":"Chronic myeloid leukemia: reminiscences and dreams","volume":"101","author":"Mughal","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.cbi.2018.04.012_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11912-017-0642-1","article-title":"Treatment-free remission: a new therapeutic goal in chronic myelogenous leukemia","volume":"19","author":"Elsayed","year":"2017","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.cbi.2018.04.012_bib4","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20130067","article-title":"Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines?","volume":"33","author":"Rumjanek","year":"2013","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.cbi.2018.04.012_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szakacs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cbi.2018.04.012_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejps.2016.03.025","article-title":"Cancer chemoresistance; biochemical and molecular aspects: a brief overview","volume":"89","author":"Kachalaki","year":"2016","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.cbi.2018.04.012_bib7","doi-asserted-by":"crossref","first-page":"84559","DOI":"10.18632\/oncotarget.19187","article-title":"Novel strategies to prevent the development of multidrug resistance (MDR) in cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2018.04.012_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15812-9","article-title":"Predicted molecular targets and pathways for germacrone, curdione, and furanodiene in the treatment of breast cancer using a bioinformatics approach","volume":"7","author":"Kong","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2018.04.012_bib9","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1080\/14786419.2017.1278600","article-title":"Chemical composition and antioxidant activity of essential oil from leaves and rhizomes of Curcuma angustifolia Roxb","volume":"31","author":"Jena","year":"2017","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.cbi.2018.04.012_bib10","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00705-016-2825-8","article-title":"In vitro antiviral effect of germacrone on feline calicivirus","volume":"161","author":"Wu","year":"2016","journal-title":"Arch. Virol."},{"key":"10.1016\/j.cbi.2018.04.012_bib11","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/ptr.5711","article-title":"Germacrone inhibits estrogen receptor \u03b1-mediated transcription in MCF-7 breast cancer cells","volume":"30","author":"Lim","year":"2016","journal-title":"Phytother. Res."},{"key":"10.1016\/j.cbi.2018.04.012_bib12","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3892\/etm.2014.1932","article-title":"Germacrone reverses Adriamycin resistance through cell apoptosis in multidrug-resistant breast cancer cells","volume":"8","author":"Xie","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cbi.2018.04.012_bib13","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3748\/wjg.v10.i9.1365","article-title":"Establishment of a P-glycoprotein substrate screening model and its preliminary application","volume":"10","author":"Wang","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cbi.2018.04.012_bib14","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3892\/mmr.2014.2290","article-title":"Germacrone inhibits the proliferation of glioma cells by promoting apoptosis and inducing cell cycle arrest","volume":"10","author":"Liu","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cbi.2018.04.012_bib15","first-page":"1331","article-title":"Adriamycin (doxorubicin)","volume":"28","author":"Ogura","year":"2001","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.cbi.2018.04.012_bib16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.gene.2016.10.016","article-title":"MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN\/Akt\/FOXO1 pathway","volume":"596","author":"Shen","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.cbi.2018.04.012_bib17","doi-asserted-by":"crossref","first-page":"9729","DOI":"10.3892\/mmr.2017.7792","article-title":"Vasohibin2 promotes adriamycin resistance of breast cancer cells through regulating ABCG2 via AKT signaling pathway","volume":"16","author":"Ma","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cbi.2018.04.012_bib18","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3892\/mmr.2017.6189","article-title":"Glycometabolic adaptation mediates the insensitivity of drug-resistant K562\/ADM leukaemia cells to adriamycin via the AKT-mTOR\/c-Myc signalling pathway","volume":"15","author":"Zhang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cbi.2018.04.012_bib19","first-page":"160","article-title":"Comparative effects of quinine and cinchonine in reversing multidrug resistance on human leukemic cell line K562\/ADM","volume":"8","author":"Genne","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.cbi.2018.04.012_bib20","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.3892\/ijo.2016.3423","article-title":"Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562\/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K\/Akt signaling pathway","volume":"48","author":"Chen","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cbi.2018.04.012_bib21","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.3109\/13880209.2013.803257","article-title":"AZT and emodin exhibit synergistic growth-inhibitory effects on K562\/ADM cells by inducing S phase cell cycle arrest and suppressing MDR1 mRNA\/p-gp protein expression","volume":"51","author":"Chen","year":"2013","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.cbi.2018.04.012_bib22","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1038\/sj.onc.1206948","article-title":"P-glycoprotein: from genomics to mechanism","volume":"22","author":"Ambudkar","year":"2003","journal-title":"Oncogene"},{"issue":"30","key":"10.1016\/j.cbi.2018.04.012_bib23","article-title":"ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal","volume":"5","author":"Choi","year":"2005","journal-title":"Canc. Cell Int."},{"key":"10.1016\/j.cbi.2018.04.012_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/cncr.11546","article-title":"The association of P-glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma. A meta-analysis","volume":"98","author":"Pakos","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.cbi.2018.04.012_bib25","first-page":"237","article-title":"Chemotherapy-induced resistance by ATP-binding cassette transporter genes","volume":"1775","author":"Gillet","year":"2007","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718301467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718301467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:48:34Z","timestamp":1757857714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279718301467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":25,"alternative-id":["S0009279718301467"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2018.04.012","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562\/ADM cells by suppressing MDR1 gene\/P-glycoprotein expression","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2018.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}